0001415889-22-001324.txt : 20220214 0001415889-22-001324.hdr.sgml : 20220214 20220214172738 ACCESSION NUMBER: 0001415889-22-001324 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220210 FILED AS OF DATE: 20220214 DATE AS OF CHANGE: 20220214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zeskind Benjamin J. CENTRAL INDEX KEY: 0001870062 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40675 FILM NUMBER: 22635177 MAIL ADDRESS: STREET 1: C/O IMMUNEERING CORPORATION STREET 2: 245 MAIN STREET, SECOND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immuneering Corp CENTRAL INDEX KEY: 0001790340 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 MAIN STREET, SECOND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-500-8080 MAIL ADDRESS: STREET 1: 245 MAIN STREET, SECOND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 form4-02142022_020219.xml X0306 4 2022-02-10 0001790340 Immuneering Corp IMRX 0001870062 Zeskind Benjamin J. 245 MAIN STREET SECOND FLOOR CAMBRIDGE MA 02142 true true true false PRESIDENT AND CEO Stock Option 9.66 2022-02-10 4 A 0 156485 0 A 2032-02-09 Class A Common Stock 156485 156485 D Stock Option 10.63 2022-02-10 4 A 0 45615 0 A 2027-02-09 Class A Common Stock 45615 202100 D The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026. The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026. /s/ Michael D. Bookman, Attorney-in-Fact for Benjamin J. Zeskind 2022-02-14